Skip to content

Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate

C37H39N7O3 — CID 126670714

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate
SMILESCOC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(C#CC#Cc3cnc([C@@H]4CCCN4)[nH]3)c(-c3ccccc3)c2)[nH]1)C(C)C
InChIInChI=1S/C37H39N7O3/c1-24(2)33(43-37(46)47-3)36(45)44-20-10-16-32(44)35-40-23-31(42-35)27-18-17-26(29(21-27)25-11-5-4-6-12-25)13-7-8-14-28-22-39-34(41-28)30-15-9-19-38-30/h4-6,11-12,17-18,21-24,30,32-33,38H,9-10,15-16,19-20H2,1-3H3,(H,39,41)(H,40,42)(H,43,46)/t30-,32-,33-/m0/s1
InChIKeyKHKCPTOBJMXVMH-RGRQWMLTSA-N
MW629.77 g/mol
LogP5.34
Rot. Bonds7

About Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate

Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate (PubChem CID 126670714) has the molecular formula C37H39N7O3 and a molecular weight of 629.77 g/mol. Its IUPAC name is methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate.

Molecular Properties

Compound NameMethyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate
PubChem CID126670714
Molecular FormulaC37H39N7O3
Molecular Weight629.77 g/mol
Exact Mass629.31
IUPAC Namemethyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate
SMILESCOC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(C#CC#Cc3cnc([C@@H]4CCCN4)[nH]3)c(-c3ccccc3)c2)[nH]1)C(C)C
InChIInChI=1S/C37H39N7O3/c1-24(2)33(43-37(46)47-3)36(45)44-20-10-16-32(44)35-40-23-31(42-35)27-18-17-26(29(21-27)25-11-5-4-6-12-25)13-7-8-14-28-22-39-34(41-28)30-15-9-19-38-30/h4-6,11-12,17-18,21-24,30,32-33,38H,9-10,15-16,19-20H2,1-3H3,(H,39,41)(H,40,42)(H,43,46)/t30-,32-,33-/m0/s1
InChIKeyKHKCPTOBJMXVMH-RGRQWMLTSA-N
XLogP5.34
TPSA128.03 Ų
H-Bond Donors4
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms47
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500629.77
LogP ≤ 55.34
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate?
The IUPAC name of Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate (CID 126670714) is methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate.
What is the SMILES notation for Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate?
The canonical SMILES for Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate is COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(C#CC#Cc3cnc([C@@H]4CCCN4)[nH]3)c(-c3ccccc3)c2)[nH]1)C(C)C.
What is the InChIKey of Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate?
The InChIKey is KHKCPTOBJMXVMH-RGRQWMLTSA-N. The full InChI is InChI=1S/C37H39N7O3/c1-24(2)33(43-37(46)47-3)36(45)44-20-10-16-32(44)35-40-23-31(42-35)27-18-17-26(29(21-27)25-11-5-4-6-12-25)13-7-8-14-28-22-39-34(41-28)30-15-9-19-38-30/h4-6,11-12,17-18,21-24,30,32-33,38H,9-10,15-16,19-20H2,1-3H3,(H,39,41)(H,40,42)(H,43,46)/t30-,32-,33-/m0/s1.
What are the key properties of Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate?
Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate has a molecular weight of 629.77 g/mol, XLogP of 5.34, 7 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for Methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[5-[3-phenyl-4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]buta-1,3-diynyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]butan-2-yl]carbamate is sourced from PubChem (CID 126670714), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.